Skip to content
Sign inOpen the app
Artwork for BioVenture VoiCes with Chris Garabedian
BioVenture VoiCes with Chris Garabedian · June 15 · 1 hr 5 min

Episode 42: Nextech's Thilo Schroeder

Having been an early investor in many recent successes such as Revolution Medicines, Peloton, and Parabilis Medicines, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.

0:00-1:05:09
Play in podnod

transcript

No transcript — this publisher did not publish one.

show notes

Having been an early investor in many recent successes such as Revolution Medicines, Peloton, and Parabilis Medicines, he describes his investment philosophy and focus on precision oncology companies. Plus, his early life, getting hands on experience in biotech at Micromet, and learning from some of the top investors and scientific advisors in the industry.

more episodes

All episodes